Trevi Therapeutics (NASDAQ:TRVI) Stock Price Expected to Rise, Oppenheimer Analyst Says
Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) had its price target increased by equities researchers at Oppenheimer from ...
Nasdaq16d
Raymond James Upgrades Trevi Therapeutics (TRVI)
Fintel reports that on March 10, 2025, Raymond James upgraded their outlook for Trevi Therapeutics (NasdaqGM:TRVI) from Outperform to Strong Buy. As of March 4, 2025, the average one-year price ...
Trevi Therapeutics (NASDAQ:TRVI) Stock Price Expected to Rise, HC Wainwright Analyst Says
Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target increased by HC Wainwright from $7.50 to $12.50 in a ...